MedTrace Logo

Prevention Program- Promoting Self Resilience, Positive Self-Image and Body Image Among Adolescents and Their Parents

NCT03540277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 420

Last updated 2022-01-24

No results posted yet for this study

Summary

Cluster-Randomized Clinical trial, which includes the development and activation of an intervention program among young adolescents and their parents. Study hypothesis is that the intervention program will yield improvement in adolescents whose parents participated in the program, in comparison with the adolescents whose parents weren't involved in the intervention. Results will be measured using the study questionnaire, to be filled out by the participants before, after, and three months after the completion of the program. The questionnaire will include validated questionnaires with good psychometric qualities. The study protocol was approved by Tel Hai College institutional review board. Parents of all participants, in the intervention and in the control group, received information about the program and the study and were asked to provide informed consent.

Conditions

  • Primary Prevention

Interventions

BEHAVIORAL

Experimental: Prevention Program "young In Favor of Myself", active parents

Prevention program: "young In Favor of Myself", with parent participation

BEHAVIORAL

Experimental: Prevention Program "young In Favor of Myself", no parental involvement

Prevention program: "young In Favor of Myself", without parent participation

Sponsors & Collaborators

  • Tel Hai College

    lead OTHER

Principal Investigators

  • Moria Golan, Prof. · Tel Hai College

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2021-12-01
Completion
2021-12-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03540277 on ClinicalTrials.gov